Eli Lilly operates in the healthcare sector as a global pharmaceutical manufacturer with commercial medicines and a broad research portfolio across immunology, oncology, and metabolic health. Eli ...

Research and development (R&D) are essential elements of Eli Lilly’s operations, enabling the company to remain at the ...

Shares of Eli Lilly & Co. LLY slid 1.34% to $1,009.52 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.69% to 6,909.51 and ...

Healthcare is the only one of the S&P 500's 11 sectors that is showing weakness on the day, with the Health Care Select Sector SPDR ETF down 0.6% in recent trading. Eli Lilly's stock was shedding 2.5% ...

Eli Lilly and Company LLY shares are up on Monday as the company benefits from positive market sentiment following Novo ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.